To repeal changes to Medicaid cost sharing requirements and the exclusion for orphan drugs under the Medicare Drug Price Negotiation Program.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, To repeal changes to Medicaid cost sharing requirements and the exclusion
for orphan drugs under the Medicare Drug Price Negotiation Program., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Foreign Policy, Immigration.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section S1: 1. Short title This Act may be cited as the Repealing the Trump Sick Tax Act.
- Section idfc3263c3044f4680a2e73be2ceae186e: 2. Repeal of changes to Medicaid cost sharing requirements Section 71120 of the Act titled An Act to provide for reconciliation pursuant to title II of H. Con....
- Section idb9b94eba21b64d6f9f2c7df801b6cc6b: 3. Repeal of changes to exclusion for orphan drugs under the Drug Price Negotiation Program Section 71203 of the Act titled An Act to provide for...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, To repeal changes to Medicaid cost sharing requirements and the exclusion for orphan drugs under the Medicare Drug Price Negotiation Program., changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Foreign Policy, Immigration
Primary Purpose
This bill, To repeal changes to Medicaid cost sharing requirements and the exclusion for orphan drugs under the Medicare Drug Price Negotiation Program., changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Peter Welch
D-VT | Primary Sponsor
Legislative Progress
IntroducedMr. Welch (for himself and Mr. Wyden) introduced the following …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "federal_implementing_agencies"
- → Federal agencies assigned duties by the bill
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology